Expressions of matrix metalloproteinase-16, autophagy-related gene 5 and autophagy-related gene 7 in children with bronchial asthma and their correlations with pulmonary function
-
摘要:目的 探讨支气管哮喘患儿外周血单个核细胞中基质金属蛋白酶-16(MMP-16)、自噬相关基因5( ATG5 )、自噬相关基因7( ATG7 )表达水平与肺功能的相关性。方法 选取哮喘患儿80例作为观察组，健康体检儿童80例作为对照组。采集观察组和对照组患儿血样，检测第1秒用力呼气容积占预计值百分比(FEV1%)、用力肺活量(FVC)、最大呼气峰流速占预计值百分比(PEF%), 计算第1秒用力呼气容积占用力肺活量的比率(FEV1/FVC)。采用实时荧光定量聚合酶链反应(qRT-PCR)法检测外周血单个核细胞 MMP-16 mRNA、 ATG5 mRNA和 ATG7 mRNA水平; 采用Pearson法分析急性发作期哮喘患儿 MMP-16 mRNA、 ATG5 mRNA、 ATG7 mRNA与肺功能指标的相关性。结果 MMP-16 mRNA、 ATG5 mRNA、 ATG7 mRNA水平在对照组患儿和观察组临床缓解期患儿及急性发作期患儿中呈依次显著升高趋势(P<0.05); FEV1%、FEV1/FVC和PEF%在对照组患儿和观察组临床缓解期患儿及急性发作期患儿中呈依次显著降低趋势(P<0.05)。急性发作期哮喘患儿外周血单个核细胞 MMP-16 mRNA与 ATG5 mRNA、 MMP-16 mRNA与 ATG7 mRNA、 ATG5 mRNA与 ATG7 mRNA均呈显著正相关(r=0.536、0.542、0.534, P<0.05), 且 MMP-16 mRNA、 ATG5 mRNA、 ATG7 mRNA均与FEV1%、FEV1/FVC、PEF%呈显著负相关(P<0.05)。与轻度组比较，中重度组外周血单个核细胞 MMP-16 mRNA、 ATG5 mRNA、 ATG7 mRNA水平较高, FEV1%、FEV1/FVC、PEF%较低，差异有统计学意义(P<0.05)。结论 哮喘患儿外周血单个核细胞 MMP-16 mRNA、 ATG5 mRNA、 ATG7 mRNA水平较高，且均与肺功能有密切联系。Abstract:Objective To investigate the correlations of expression levels of matrix metalloproteinase-16 (MMP-16), autophagy-related gene 5 ( ATG5 ) and autophagy-related gene 7( ATG7 ) in peripheral blood mononuclear cells with pulmonary function in children with bronchial asthma.Methods Eighty children with asthma were selected as observation group, and eighty healthy children were selected as control group. Blood samples were collected from the observation group and control group, the forced expiratory volume in the first second as a percentage of the predicted value (FEV1%), forced vital capacity (FVC) and maximum peak expiratory flow as a percentage of the predicted value (PEF%) were detected, and ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC) was calculated. Real-time fluorescent quantitative PCR (qRT-PCR) method was used to detect the levels of MMP-16 mRNA, ATG5 mRNA and ATG7 mRNA in peripheral blood mononuclear cells; Pearson method was used to analyze the correlations of MMP-16 mRNA, ATG5 mRNA and ATG7 mRNA with pulmonary function indexes in children with acute asthma.Results The levels of MMP-16 mRNA, ATG5 mRNA and ATG7 mRNA were significantly and successively increased in the control group and the children with clinical remission and acute attack in the observation group (P<0.05); FEV1%, FEV1/FVC and PEF% were significantly and successively reduced in the control group and the children with clinical remission and acute attack in the observation group (P<0.05). There were significant positive correlations between MMP-16 mRNA and ATG5 mRNA, MMP-16 mRNA and ATG7 mRNA, and ATG5 mRNA and ATG7 mRNA in peripheral blood mononuclear cells of children with acute asthma (r=0.536, 0.542, 0.534, P<0.05), and MMP-16 mRNA, ATG5 mRNA, ATG7 mRNA were negatively correlated with FEV1%, FEV1/FVC and PEF% (P<0.05). Compared with the mild group, the levels of MMP-16 mRNA, ATG5 mRNA and ATG7 mRNA in peripheral blood mononuclear cells of the moderate to severe group were significantly higher, while the FEV1%, FEV1/FVC and PEF% were significantly lower (P<0.05).Conclusion The levels of MMP-16 mRNA, ATG5 mRNA and ATG7 mRNA in peripheral blood mononuclear cells of children with asthma are higher, and these indexes are closely related to pulmonary function.
-
-
![]()
图 1 急性发作期哮喘患儿外周血单个核细胞MMP-16 mRNA、ATG5 mRNA、ATG7 mRNA的相关性
A: MMP-16 mRNA与ATG5 mRNA的相关性; B: MMP-16 mRNA与ATG7 mRNA的相关性; C: ATG5 mRNA与ATG7 mRNA的相关性。
表 1 qRT-PCR引物序列
基因 上游引物5′-3′ 下游引物5′-3′ MMP-16 GTACGATACTCACAGCTGTAG CTCTAGCGTAGGTATGACTCG ATG5 CATATCAGAGTGCTAGATGCG GATCAATACATGCAGTCCTGG ATG7 CGTTGCAGCATGGACCATGG CTCTAGCGCTACGTAGTGCGTA GAPDH CGGGTCAGACCACTGCGAT CGGACCCATGACTGGTACCAG 
下载: 导出CSV
表 2 观察组与对照组外周血单个核细胞MMP-16 mRNA、ATG5 mRNA和ATG7 mRNA水平比较(x±s)
组别 分期 MMP-16 mRNA ATG5 mRNA ATG7 mRNA 对照组(n=80) - 1.01±0.21 0.99±0.20 1.02±0.22 观察组(n=80) 临床缓解期 1.52±0.23* 1.73±0.28* 1.66±0.30* 急性发作期 2.73±0.34*# 3.02±0.38*# 2.64±0.32*# MMP-16: 基质金属蛋白酶-16; ATG5: 自噬相关基因5; ATG7: 自噬相关基因7。
与对照组比较, * P<0.05; 与临床缓解期比较, #P<0.05。
下载: 导出CSV
表 3 观察组与对照组肺功能指标比较(x±s)
% 组别 分期 FEV1% FEV1/FVC PEF% 对照组(n=80) - 92.98±6.42 93.42±6.84 89.42±3.67 观察组(n=80) 临床缓解期 86.15±4.78* 85.42±5.71* 76.38±5.15* 急性发作期 65.24±4.71*# 73.05±6.38*# 58.66±6.13*# FEV1%: 第1秒用力呼气容积占预计值百分比; FEV1/FVC: 第1秒用力呼气容积占用力肺活量的比率;
PEF%: 最大呼气峰流速占预计值百分比。与对照组比较, * P<0.05; 与临床缓解期比较, #P<0.05。
下载: 导出CSV
表 4 急性发作期哮喘患儿外周血单个核细胞MMP-16 mRNA、ATG5 mRNA、ATG7 mRNA与肺功能指标的相关性
指标 MMP-16 mRNA ATG5 mRNA ATG7 mRNA r P r P r P FEV1% -0.512 0.006 -0.524 0.004 -0.509 0.009 FEV1/FVC -0.496 0.008 -0.507 0.005 -0.517 0.006 PEF% -0.514 0.007 -0.513 0.002 -0.497 0.010 MMP-16 : 基质金属蛋白酶-16; ATG5: 自噬相关基因5; ATG7: 自噬相关基因7; FEV1%: 第1秒用力呼气容积占预计值百分比; FEV1/FVC: 第1秒用力呼气容积占用力肺活量的比率; PEF%: 最大呼气峰流速占预计值百分比。
下载: 导出CSV
表 5 轻度组与中重度组外周血单个核细胞MMP-16 mRNA、ATG5 mRNA、ATG7 mRNA及肺功能指标比较(x±s)
组别 n MMP-16 mRNA ATG5 mRNA ATG7 mRNA FEV1%/% FEV1/FVC/% PEF%/% 轻度组 46 2.38±0.31 2.62±0.37 2.10±0.30 72.31±4.67 78.42±6.15 64.14±4.32 中重度组 34 3.20±0.34* 3.56±0.42* 3.37±0.35* 55.67±3.62* 65.78±5.20* 51.25±4.09* MMP-16 : 基质金属蛋白酶-16; ATG5: 自噬相关基因5; ATG7: 自噬相关基因7; FEV1%: 第1秒用力呼气容积占预计值百分比; FEV1/FVC: 第1秒用力呼气容积占用力肺活量的比率; PEF%: 最大呼气峰流速占预计值百分比。与轻度组比较, * P<0.05。
下载: 导出CSV
-
[1] CAFFREY OSVALD E, BOWER H, LUNDHOLM C, et al. Asthma and all-cause mortality in children and young adults: a population-based study[J]. Thorax, 2020, 75(12): 1040-1046. doi: 10.1136/thoraxjnl-2020-214655
[2] 张洋, 侯伟. 儿童支气管哮喘心理行为问题研究进展[J]. 中国儿童保健杂志, 2019, 27(5): 523-526. https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO201905015.htm [3] LIB B, CHENY L, PANG F Z. microRNA-30a targets ATG5 and attenuates airway fibrosis in asthma by suppressing autophagy[J]. Inflammation, 2020, 43(1): 44-53. doi: 10.1007/s10753-019-01076-0
[4] LOU L L, TIAN M Y, CHANG J X, et al. MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7[J]. Biomed Pharmacother, 2020, 122: 109692. doi: 10.1016/j.biopha.2019.109692
[5] 洪建国. 儿童支气管哮喘规范化诊治建议(2020年版)[J]. 中华儿科杂志, 2020, 58(9): 708-717. doi: 10.3760/cma.j.cn112140-20200604-00578 [6] 赵丽丽, 丁显春. 促纤维化细胞因子在儿童支气管哮喘中的表达特点及与肺功能的相关性研究[J]. 临床肺科杂志, 2019, 24(3): 446-450. doi: 10.3969/j.issn.1009-6663.2019.03.015 [7] CHENGS L. Immunologic pathophysiology and airway remodeling mechanism in severe asthma: focused on IgE-mediated pathways[J]. Diagnostics (Basel), 2021, 11(1): 83. doi: 10.3390/diagnostics11010083
[8] 程丹, 胡克. 气道上皮屏障功能异常在支气管哮喘发病中的作用[J]. 国际呼吸杂志, 2020, 40(2): 146-150. doi: 10.3760/cma.j.issn.1673-436X.2020.02.013 [9] MARTINM J, BEASLEY R, HARRISONT W. Towards a personalised treatment approach for asthma attacks[J]. Thorax, 2020, 75(12): 1119-1129. doi: 10.1136/thoraxjnl-2020-214692
[10] WANG W F, LIU Y P, YANG Y X, et al. MMP-16 as a new biomarker for predicting prognosis and chemosensitivity of serous ovarian cancer: a study based on bioinformatics analysis[J]. Crit Rev Eukaryot Gene Expr, 2021, 31(4): 1-8. doi: 10.1615/CritRevEukaryotGeneExpr.2021037805
[11] 徐杰, 徐鹏, 李梦娇, 等. miR-24-3p靶向MMP-16对鼻咽癌5-8F细胞侵袭、迁移和裸鼠成瘤的影响[J]. 中国免疫学杂志, 2020, 36(13): 1589-1593. doi: 10.3969/j.issn.1000-484X.2020.13.010 [12] DUANX J, ZHANG X, DING N, et al. LncRNA NEAT1 regulates MMP-16 by targeting miR-200a/b to aggravate inflammation in asthma[J]. Autoimmunity, 2021, 54(7): 439-449. doi: 10.1080/08916934.2021.1966769
[13] RACANELLIA C, KIKKERSS A, CHOIA M K, et al. Autophagy and inflammation in chronic respiratory disease[J]. Autophagy, 2018, 14(2): 221-232. doi: 10.1080/15548627.2017.1389823
[14] 陈银慧, 毛晓宁, 吴锐剑, 等. 自噬在支气管哮喘发病中的作用及其相关治疗药物研究进展[J]. 山东医药, 2019, 59(35): 109-112. doi: 10.3969/j.issn.1002-266X.2019.35.030 [15] SUN S L, SHEN Y H, WANG J, et al. Identification and validation of autophagy-related genes in chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16: 67-78. doi: 10.2147/COPD.S288428
[16] 王雪松, 寿松涛, 姚咏明. 自噬相关基因ATG5在感染和炎症性疾病中的作用[J]. 生理科学进展, 2020, 51(5): 337-341. doi: 10.3969/j.issn.0559-7765.2020.05.004 [17] 胡红霞, 宋恩学, 詹磊, 等. 子宫内膜异位症患者中自噬相关基因5和基质金属蛋白酶9的表达及相关性[J]. 实用妇产科杂志, 2021, 37(4): 287-290. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ202104018.htm -
期刊类型引用(13)
1. 刘倩. 难治性胃食管反流病的中医疗法研究近况. 湖北中医杂志. 2023(11): 63-66 . 
百度学术
2. 杨超，陈莉丽，杨振斌. 方晓华抑木扶土法临床运用验案举隅. 中国民间疗法. 2022(14): 105-108 . 百度学术
3. 郭丽，夏军权，刘晓桐. 难治性胃食管反流病中医药诊治研究进展. 光明中医. 2021(22): 3790-3793 . 百度学术
4. 贾军峰，李文萍. 和胃降逆饮联合西药及针刺治疗残胃引起的反流性食管炎的疗效及对血清胃动素的影响. 中国中西医结合消化杂志. 2020(12): 944-948 . 百度学术
5. 刘妍. 疏肝降逆汤联合中医特色护理治疗胃食管反流病效果研究. 药品评价. 2019(01): 44-46 . 百度学术
6. 马雪梅. 和胃降逆汤加减联合奥美拉唑、枸橼酸莫沙必利治疗肝胃郁热型胃食管反流病的临床观察. 中国民间疗法. 2019(05): 55-56 . 百度学术
7. 房晓娜. 和胃降逆汤加减治疗胃食管反流病肝胃郁热型临床观察. 实用中医药杂志. 2019(04): 413-414 . 百度学术
8. 邓粉会. 自拟和胃降逆汤辅助西药治疗胃食管反流病相关性支气管哮喘疗效观察. 人人健康. 2019(24): 114-115 . 百度学术
9. 黄太伟. 半夏厚朴汤加减治疗难治性胃食管反流病的疗效研究. 实用医技杂志. 2018(06): 625-626 . 百度学术
10. 高钟. 泮托拉唑、香砂养胃丸、左金丸联用治疗胃食管反流病的效果观察. 中国社区医师. 2018(19): 102-103 . 百度学术
11. 姚向东. 雷贝拉唑、莫沙必利与玄麦甘桔三联用药治疗咽喉反流疾病的临床疗效. 中国合理用药探索. 2018(02): 8-11 . 百度学术
12. 王巧凤，王胜业. 和胃降逆汤加减治疗肝胃郁热型胃食管反流病疗效观察. 北方药学. 2018(11): 131 . 百度学术
13. 王茜茜，李华岳. 加减乌梅丸方联合穴位针刺对胃食管反流病患者食管动力的影响. 中国中医药现代远程教育. 2018(23): 42-44 . 百度学术
其他类型引用(7)
计量
- 文章访问数: 249
- HTML全文浏览量: 169
- PDF下载量: 10
- 被引次数: 20
苏公网安备 32100302010246号
